A small medical device startup in Silicon Valley is leveraging the U.S. International Trade Commission (ITC) to litigate allegations of intellectual property infringement against technology giant, Apple Inc. The dispute centers around Apple’s purported misappropriation of health tracking software used in their smartwatches.
The accusations have managed to pull notable attention and support in the form of amicus briefs from varying quarters of the industry. Key amongst their backers are several trade groups, a well-known billionaire venture capitalist, and a notable Japanese manufacturer of health monitors.
The submission of these amicus briefs highlights a burgeoning call for the Federal Circuit to respect the ITC’s jurisdiction and authority in handling allegations of this nature. However, the extent to which these calls will influence the ongoing legal proceedings remains to be seen.
High-profile disputes of this nature underscore the complex nature of intellectual property rights in sectors marrying technology and health care. They also underscore the role bodies like the ITC play in arbitrating these complex and often far-reaching disputes.
For more detailed information, it is recommended to read the available analysis on Law360.